AL
Therapeutic Areas
GT Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GTB-3650 TriKE® | Relapsed/Refractory CD33+ hematologic malignancies (Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome) | Phase 1 |
| GTB-5550 TriKE® | Metastatic Solid Tumors (Basket: Prostate, Ovarian, Breast, Head & Neck, NSCLC, Pancreatic, Bladder Cancers) | Phase 1 (Planned) |